ID   PURA1_HUMAN             Reviewed;         457 AA.
AC   Q8N142; Q86TT6; Q8N714;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   10-MAY-2017, entry version 144.
DE   RecName: Full=Adenylosuccinate synthetase isozyme 1 {ECO:0000255|HAMAP-Rule:MF_03126};
DE            Short=AMPSase 1 {ECO:0000255|HAMAP-Rule:MF_03126};
DE            Short=AdSS 1 {ECO:0000255|HAMAP-Rule:MF_03126};
DE            EC=6.3.4.4 {ECO:0000255|HAMAP-Rule:MF_03126, ECO:0000269|PubMed:26506222};
DE   AltName: Full=Adenylosuccinate synthetase, basic isozyme {ECO:0000255|HAMAP-Rule:MF_03126};
DE   AltName: Full=Adenylosuccinate synthetase, muscle isozyme {ECO:0000255|HAMAP-Rule:MF_03126};
DE            Short=M-type adenylosuccinate synthetase {ECO:0000255|HAMAP-Rule:MF_03126};
DE   AltName: Full=IMP--aspartate ligase 1 {ECO:0000255|HAMAP-Rule:MF_03126};
GN   Name=ADSSL1 {ECO:0000255|HAMAP-Rule:MF_03126};
GN   Synonyms=ADSS1 {ECO:0000255|HAMAP-Rule:MF_03126};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow stroma;
RX   PubMed=15786719; DOI=10.1007/s11010-005-2539-9;
RA   Sun H., Li N., Wang X., Chen T., Shi L., Zhang L., Wang J., Wan T.,
RA   Cao X.;
RT   "Molecular cloning and characterization of a novel muscle
RT   adenylosuccinate synthetase, AdSSL1, from human bone marrow stromal
RT   cells.";
RL   Mol. Cell. Biochem. 269:85-94(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, INVOLVEMENT IN MPD5, VARIANT
RP   MPD5 ASN-261, AND CHARACTERIZATION OF VARIANT MPD5 ASN-261.
RX   PubMed=26506222; DOI=10.1002/ana.24550;
RA   Park H.J., Hong Y.B., Choi Y.C., Lee J., Kim E.J., Lee J.S., Mo W.M.,
RA   Ki S.M., Kim H.I., Kim H.J., Hyun Y.S., Hong H.D., Nam K., Jung S.C.,
RA   Kim S.B., Kim S.H., Kim D.H., Oh K.W., Kim S.H., Yoo J.H., Lee J.E.,
RA   Chung K.W., Choi B.O.;
RT   "ADSSL1 mutation relevant to autosomal recessive adolescent onset
RT   distal myopathy.";
RL   Ann. Neurol. 79:231-243(2016).
CC   -!- FUNCTION: Component of the purine nucleotide cycle (PNC), which
CC       interconverts IMP and AMP to regulate the nucleotide levels in
CC       various tissues, and which contributes to glycolysis and
CC       ammoniagenesis. Catalyzes the first committed step in the
CC       biosynthesis of AMP from IMP. {ECO:0000269|PubMed:26506222}.
CC   -!- CATALYTIC ACTIVITY: GTP + IMP + L-aspartate = GDP + phosphate +
CC       N(6)-(1,2-dicarboxyethyl)-AMP. {ECO:0000255|HAMAP-Rule:MF_03126,
CC       ECO:0000269|PubMed:26506222}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03126};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_03126};
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway;
CC       AMP from IMP: step 1/2. {ECO:0000255|HAMAP-Rule:MF_03126,
CC       ECO:0000269|PubMed:26506222}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_03126}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03126,
CC       ECO:0000269|PubMed:15786719}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N142-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N142-2; Sequence=VSP_008421;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in skeletal muscle and
CC       heart, as well as in several hematopoietic cell lines and solid
CC       tumors. {ECO:0000269|PubMed:15786719}.
CC   -!- DISEASE: Myopathy, distal, 5 (MPD5) [MIM:617030]: A form of distal
CC       myopathy, a group of muscular disorders characterized by
CC       progressive muscular weakness and muscle atrophy beginning in the
CC       hands, the legs or the feet. MPD5 is an autosomal recessive form,
CC       predominantly affecting the lower limbs.
CC       {ECO:0000269|PubMed:26506222}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenylosuccinate synthetase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03126}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH32039.1; Type=Frameshift; Positions=1; Evidence={ECO:0000305};
CC       Sequence=CAD62614.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY037159; AAK67646.1; -; mRNA.
DR   EMBL; AK095921; BAC04649.1; -; mRNA.
DR   EMBL; BX248286; CAD62614.1; ALT_INIT; mRNA.
DR   EMBL; BC032039; AAH32039.1; ALT_FRAME; mRNA.
DR   EMBL; BC047904; AAH47904.1; -; mRNA.
DR   CCDS; CCDS9990.1; -. [Q8N142-1]
DR   CCDS; CCDS9991.1; -. [Q8N142-2]
DR   RefSeq; NP_001307353.1; NM_001320424.1.
DR   RefSeq; NP_689541.1; NM_152328.4. [Q8N142-1]
DR   RefSeq; NP_954634.1; NM_199165.2. [Q8N142-2]
DR   UniGene; Hs.592327; -.
DR   PDB; 2GJO; Model; -; A=27-457.
DR   PDBsum; 2GJO; -.
DR   ProteinModelPortal; Q8N142; -.
DR   SMR; Q8N142; -.
DR   BioGrid; 125783; 3.
DR   IntAct; Q8N142; 3.
DR   MINT; MINT-3319213; -.
DR   STRING; 9606.ENSP00000333019; -.
DR   DrugBank; DB03510; 6-O-Phosphoryl Inosine Monophosphate.
DR   DrugBank; DB04418; Adenylosuccinic Acid.
DR   DrugBank; DB04315; Guanosine-5'-Diphosphate.
DR   DrugBank; DB04137; Guanosine-5'-Triphosphate.
DR   DrugBank; DB02109; Hadacidin.
DR   DrugBank; DB04566; Inosinic Acid.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   iPTMnet; Q8N142; -.
DR   PhosphoSitePlus; Q8N142; -.
DR   BioMuta; ADSSL1; -.
DR   DMDM; 37537958; -.
DR   EPD; Q8N142; -.
DR   MaxQB; Q8N142; -.
DR   PaxDb; Q8N142; -.
DR   PeptideAtlas; Q8N142; -.
DR   PRIDE; Q8N142; -.
DR   Ensembl; ENST00000330877; ENSP00000331260; ENSG00000185100. [Q8N142-1]
DR   Ensembl; ENST00000332972; ENSP00000333019; ENSG00000185100. [Q8N142-2]
DR   GeneID; 122622; -.
DR   KEGG; hsa:122622; -.
DR   UCSC; uc001ypd.5; human. [Q8N142-1]
DR   CTD; 122622; -.
DR   DisGeNET; 122622; -.
DR   GeneCards; ADSSL1; -.
DR   HGNC; HGNC:20093; ADSSL1.
DR   MIM; 612498; gene.
DR   MIM; 617030; phenotype.
DR   neXtProt; NX_Q8N142; -.
DR   OpenTargets; ENSG00000185100; -.
DR   PharmGKB; PA134974111; -.
DR   eggNOG; KOG1355; Eukaryota.
DR   eggNOG; COG0104; LUCA.
DR   GeneTree; ENSGT00390000015553; -.
DR   HOGENOM; HOG000260959; -.
DR   HOVERGEN; HBG053768; -.
DR   InParanoid; Q8N142; -.
DR   KO; K01939; -.
DR   OMA; SNGVRCD; -.
DR   OrthoDB; EOG091G1BIK; -.
DR   PhylomeDB; Q8N142; -.
DR   TreeFam; TF300486; -.
DR   BRENDA; 6.3.4.4; 2681.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   UniPathway; UPA00075; UER00335.
DR   GenomeRNAi; 122622; -.
DR   PRO; PR:Q8N142; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000185100; -.
DR   CleanEx; HS_ADSSL1; -.
DR   ExpressionAtlas; Q8N142; baseline and differential.
DR   Genevisible; Q8N142; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0004019; F:adenylosuccinate synthase activity; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; NAS:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042301; F:phosphate ion binding; NAS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0044208; P:'de novo' AMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006167; P:AMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006531; P:aspartate metabolic process; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:Ensembl.
DR   GO; GO:0002376; P:immune system process; NAS:UniProtKB.
DR   GO; GO:0046040; P:IMP metabolic process; IBA:GO_Central.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   GO; GO:0014850; P:response to muscle activity; IEA:Ensembl.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   CDD; cd03108; AdSS; 1.
DR   HAMAP; MF_00011; Adenylosucc_synth; 1.
DR   HAMAP; MF_03126; Adenylosucc_synth_vert_basic; 1.
DR   InterPro; IPR018220; Adenylosuccin_syn_GTP-bd.
DR   InterPro; IPR033128; Adenylosuccin_syn_Lys_AS.
DR   InterPro; IPR001114; Adenylosuccinate_synthetase.
DR   InterPro; IPR027509; AdSS_1_vert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11846; PTHR11846; 1.
DR   Pfam; PF00709; Adenylsucc_synt; 1.
DR   SMART; SM00788; Adenylsucc_synt; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00184; purA; 1.
DR   PROSITE; PS01266; ADENYLOSUCCIN_SYN_1; 1.
DR   PROSITE; PS00513; ADENYLOSUCCIN_SYN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Disease mutation; GTP-binding; Ligase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Purine biosynthesis; Reference proteome.
FT   CHAIN         1    457       Adenylosuccinate synthetase isozyme 1.
FT                                /FTId=PRO_0000095132.
FT   NP_BIND      42     48       GTP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   NP_BIND      70     72       GTP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   NP_BIND     363    365       GTP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   NP_BIND     445    448       GTP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   REGION       43     46       IMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03126}.
FT   REGION       68     71       IMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03126}.
FT   REGION      331    337       Substrate binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03126}.
FT   ACT_SITE     43     43       Proton acceptor. {ECO:0000255|HAMAP-
FT                                Rule:MF_03126}.
FT   ACT_SITE     71     71       Proton donor. {ECO:0000255|HAMAP-
FT                                Rule:MF_03126}.
FT   METAL        43     43       Magnesium. {ECO:0000255|HAMAP-
FT                                Rule:MF_03126}.
FT   METAL        70     70       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   BINDING      43     43       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03126}.
FT   BINDING     163    163       IMP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   BINDING     177    177       IMP; shared with dimeric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   BINDING     256    256       IMP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   BINDING     271    271       IMP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   BINDING     335    335       IMP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   BINDING     337    337       GTP. {ECO:0000255|HAMAP-Rule:MF_03126}.
FT   VAR_SEQ       1     64       MSGTRASNDRPPGAGGVKRGRLQQEAAATGSRVTVVLGAQW
FT                                GDEGKGKVVDLLATDADIISRCQ -> MVGRSCGVATQRQG
FT                                GGQRPTNLALTLSSSPAHSTALPWLPPRSLQLLSGHSVPAQ
FT                                PTPHLPSACGGPTRVTLGEERAWRSHGSNAGGHTCLPRRTA
FT                                GAGSLTPGGER (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008421.
FT   VARIANT     261    261       D -> N (in MPD5; decreased protein
FT                                abundance; decreased stability; decreased
FT                                adenylosuccinate synthase activity;
FT                                dbSNP:rs140614802).
FT                                {ECO:0000269|PubMed:26506222}.
FT                                /FTId=VAR_076998.
SQ   SEQUENCE   457 AA;  50208 MW;  387341D49721B2EF CRC64;
     MSGTRASNDR PPGAGGVKRG RLQQEAAATG SRVTVVLGAQ WGDEGKGKVV DLLATDADII
     SRCQGGNNAG HTVVVDGKEY DFHLLPSGII NTKAVSFIGN GVVIHLPGLF EEAEKNEKKG
     LKDWEKRLII SDRAHLVFDF HQAVDGLQEV QRQAQEGKNI GTTKKGIGPT YSSKAARTGL
     RICDLLSDFD EFSSRFKNLA HQHQSMFPTL EIDIEGQLKR LKGFAERIRP MVRDGVYFMY
     EALHGPPKKI LVEGANAALL DIDFGTYPFV TSSNCTVGGV CTGLGIPPQN IGDVYGVVKA
     YTTRVGIGAF PTEQINEIGG LLQTRGHEWG VTTGRKRRCG WLDLMILRYA HMVNGFTALA
     LTKLDILDVL GEVKVGVSYK LNGKRIPYFP ANQEMLQKVE VEYETLPGWK ADTTGARRWE
     DLPPQAQNYI RFVENHVGVA VKWVGVGKSR ESMIQLF
//
